# A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD Patients

> **NCT01836016** · PHASE3 · UNKNOWN · sponsor: **Henan University of Traditional Chinese Medicine** · enrollment: 360 (estimated)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Salbutamol (Ventolin®)
- **DRUG:** Formoterol (Oxis Turbuhaler®)
- **DRUG:** Salmeterol / fluticasone (Seretide®)
- **DRUG:** Bufei granule
- **DRUG:** Bufeijianpi granule
- **DRUG:** Bufeiyishen granule
- **DRUG:** Yiqizishen granule
- **DRUG:** conventional medicine + TCM

## Key facts

- **NCT ID:** NCT01836016
- **Lead sponsor:** Henan University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2013-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01836016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01836016, "A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01836016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*